低剂量阿司匹林预防复发性早产的胎盘MVM分层分析
对APRIL研究进行二次分析,纳入既往自发性早产且有前次胎盘病理报告的160例女性。按阿姆斯特丹标准评估胎盘母体血管灌注不良(MVM),MVM阳性者占27.5%。在MVM阳性者中,阿司匹林组复发性早产率为4.2%,安慰剂组为45.0%,阿司匹林与更低复发风险相关。
要点
- 既往自发性早产且前次胎盘存在MVM者,后续妊娠使用低剂量阿司匹林可显著降低复发性早产率。
- 无MVM者中阿司匹林组与安慰剂组复发性早产率差异无统计学意义。
- 胎盘MVM可作为识别可能从低剂量阿司匹林获益的复发性早产高风险女性的病理指标。
核心结论
- 在既往自发性早产且前次胎盘存在母体血管灌注不良(MVM)的血管介导亚组中,后续妊娠使用低剂量阿司匹林与复发性早产率降低相关。
研究设计与样本
- APRIL研究的二次分析,APRIL研究在荷兰34个中心进行,比较低剂量阿司匹林与安慰剂预防自发性早产后复发性早产的效果。
- 纳入APRIL研究中既往有自发性早产史且可获取前次自发性早产胎盘病理报告的160例女性。
- 根据阿姆斯特丹标准对前次胎盘病理报告进行MVM分类。
主要发现
- 160例中MVM阳性44例,占27.5%。
- MVM阳性者中,阿司匹林组复发性早产率为4.2%(1/24),安慰剂组为45.0%(9/20),RR 0.09,95%CI 0.01–0.43,p=0.02。
- 无MVM者中,阿司匹林组复发性早产率为29.3%(17/58),安慰剂组为17.2%(10/58),RR 1.70,95%CI 0.87–3.56,p=0.13。
- 前次自发性早产的胎盘病理报告可获取率为41.3%(160/387)。
关键数值与推荐
- MVM定义依据阿姆斯特丹标准。
- MVM阳性者阿司匹林组与安慰剂组复发性早产率:4.2%(1/24)对45.0%(9/20),RR 0.09,95%CI 0.01–0.43,p=0.02。
- 无MVM者阿司匹林组与安慰剂组复发性早产率:29.3%(17/58)对17.2%(10/58),RR 1.70,95%CI 0.87–3.56,p=0.13。
临床怎么用
- 对于既往自发性早产且前次胎盘病理提示MVM的女性,后续妊娠考虑使用低剂量阿司匹林可能降低复发性早产风险。
- 胎盘病理中的MVM可作为筛选可能从低剂量阿司匹林获益人群的参考指标。
局限性
- 仅41.3%的APRIL研究参与者可获取前次胎盘病理报告。
- MVM阳性亚组样本量较小,阿司匹林组24例,安慰剂组20例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Objective To evaluate the effectiveness of low-dose aspirin in the prevention of recurrent preterm birth (PTB) in women with signs of maternal vascular malperfusion (MVM) in the placenta of the previous spontaneous PTB. Design Secondary analysis of the APRIL study. Setting The APRIL study, conducted in 34 centres in the Netherlands, evaluated low-dose aspirin versus placebo in the prevention of recurrent PTB after spontaneous PTB. Population Women with a history of spontaneous PTB participating in the APRIL study, with available placenta histology reports from the previous spontaneous PTB. Methods Placental histology reports were retrieved from participating centres and categorized for presence of MVM as defined by the Amsterdam criteria. Main Outcome Measures Recurrent PTB. Results Placental histology reports of the previous spontaneous PTB were available for 41.3% (160/387) of participants, and MVM was present in 27.5% (44/160). In participants with MVM, recurrent PTB occurred in 4.2% (1/24) of the aspirin group, versus in 45.0% (9/20) in the placebo group (Relative Risk (RR) 0.09; 95% Confidence Interval (CI) 0.01–0.43; p = 0.02). In participants without MVM, PTB occurred in 29.3% (17/58) in the aspirin group compared to 17.2% (10/58) in the placebo group (RR 1.70; 95% CI 0.87–3.56; p = 0.13). Conclusion In women with a history of spontaneous PTB and signs of MVM in the placenta, a vascular-mediated subgroup, the use of low-dose aspirin in a subsequent pregnancy was associated with a lower rate of recurrent PTB.
引用
- BJOG:Low‐Dose Aspirin in the Prevention of Recurrent Spontaneous Preterm Birth Stratified by Placental Maternal Vascular Malperfusion: Secondary Analysis of a Randomized Trial
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。